Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 1—January 2007
Research

Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England

Cheryl Cohen*1Comments to Author , Joanne M. White†, Emma J. Savage†, Judith R. Glynn*, Yoon Choi†, Nick Andrews†, David Brown†, and Mary E. Ramsay†
Author affiliations: *London School of Hygiene and Tropical Medicine, London, United Kingdom; †Health Protection Agency Centre for Infections, London, United Kingdom; 1Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa

Main Article

Table 3

Age-specific estimates of vaccine effectiveness for 1 and 2 doses of measles, mumps, rubella vaccine

Age group, yEffectiveness
1 dose, % (95% CI*)2 doses, % (95% CI*)
295.9 (81.1–99.1)
5–693.8 (84.1–97.6)98.8 (97.0–99.5)
7–890.3 (81.2–95.0)95.8 (92.9–97.5)
9–1086.5 (75.3–92.6)92.4 (87.7–95.3)
11–1265.9 (30.3–83.3)86.4 (74.1–92.9)

*CI, confidence interval; p for linear trend <0.001 for 1 and 2 doses.

Main Article

1Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa

Page created: January 22, 2013
Page updated: January 22, 2013
Page reviewed: January 22, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external